Long‐Term Effects of Nusinersen Dosing Frequency on Adult Patients With Spinal Muscular Atrophy: Efficacy of a 6‐Month Dosing Interval

Documenti analoghi

• Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy
  di: Hüseyin Bahadır Şenol, et al.
  Pubblicazione: (2025)
• Transfer of Motor and Perceptual Learning in Parkinson’s Disease
  di: Naohisa Ueda, et al.
  Pubblicazione: (2025)
• Examination of the Peripheral Nervous System in Children With Spinal Muscular Atrophy: A High‐Resolution Ultrasonographic Study
  di: Janina Wurster, et al.
  Pubblicazione: (2026)
• Comparative Efficacy and Safety of Different Tenecteplase Doses With Alteplase in Acute Ischemic Stroke: A Systematic Review With Pairwise and Network Meta‐Analysis to Determine the Optimal Dose
  di: Muhammad Hassan Waseem, et al.
  Pubblicazione: (2025)
• The Relationship Between Body Mass Index and Recurrence Risk of Stroke: A Systematic Review and Dose–Response Meta‑Analysis
  di: Qiuxia Qian, et al.
  Pubblicazione: (2025)